|
|
||||||||
1 From the Cell and Molecular Biology Unit, Department of Optometry and Vision Sciences, University of Cardiff, United Kingdom; and the 2 Department of Ophthalmology, Manchester Royal Eye Hospital, United Kingdom.
PURPOSE. Retinal pigment epithelial (RPE) cells are believed to play a pivotal role in the formation and contraction of epiretinal membranes in proliferative vitreoretinopathy (PVR). In the present study, an organ culture method was used that mimics the contractile stage of PVR, to investigate the contribution of a variety of growth factors in human RPE cellmediated contraction of the retina.
METHODS. Cultured human RPE cells were seeded onto bovine retinal explants. After attachment, cultures received one of the following exogenous growth factors: platelet-derived growth factor (PDGF)-AB, PDGF-BB, basic fibroblast growth factor (bFGF), transforming growth factor (TGF)-ß1, TGF-ß2, or interleukin (IL)-10; or a neutralizing antibody to PDGF and/or TGF-ß2. Control explants were either untreated or received a null antibody. Contraction was assessed by image analysis and expressed as percentage reduction in retinal area.
RESULTS. RPE cells produced a more than 50% contraction of the retina after 7 days in untreated samples. PDGF and TGF-ß2 stimulated RPE-mediated contraction by a further 20% at 100 ng/ml. IL-10 decreased contraction by 63%, whereas the other growth factors gave rise to similar contraction to untreated controls. Neutralizing antibodies against PDGF and TGF-ß2 reduced RPE-mediated contraction by up to 70% in comparison with untreated controls. The neutralizing antibodies also inhibited the effects of exogenous PDGF and TGF-ß2 on RPE-mediated contraction of the retina (P < 0.01).
CONCLUSIONS. These findings confirm a role for both PDGF and TGF-ß2 in RPE cellmediated contraction of the retina. Such contraction can be inhibited by neutralizing antibodies against PDGF and TGF-ß2, which, together with IL-10, are putative candidates for therapeutic intervention in PVR.
This article has been cited by other articles:
![]() |
H. Lei, P. Hovland, G. Velez, A. Haran, D. Gilbertson, T. Hirose, and A. Kazlauskas A Potential Role for PDGF-C in Experimental and Clinical Proliferative Vitreoretinopathy Invest. Ophthalmol. Vis. Sci., May 1, 2007; 48(5): 2335 - 2342. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Saika, O. Yamanaka, I. Nishikawa-Ishida, A. Kitano, K. C. Flanders, Y. Okada, Y. Ohnishi, Y. Nakajima, and K. Ikeda Effect of Smad7 Gene Overexpression on Transforming Growth Factor beta-Induced Retinal Pigment Fibrosis in a Proliferative Vitreoretinopathy Mouse Model Arch Ophthalmol, May 1, 2007; 125(5): 647 - 654. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Carrington, J. Albon, I. Anderson, C. Kamma, and M. Boulton Differential Regulation of Key Stages in Early Corneal Wound Healing by TGF-{beta} Isoforms and Their Inhibitors Invest. Ophthalmol. Vis. Sci., May 1, 2006; 47(5): 1886 - 1894. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. H. Eibl, D. Kook, S. Priglinger, C. Haritoglou, A. Yu, A. Kampik, and U. Welge-Lussen Inhibition of Human Retinal Pigment Epithelial Cell Attachment, Spreading, and Migration by Alkylphosphocholines Invest. Ophthalmol. Vis. Sci., January 1, 2006; 47(1): 364 - 370. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hirayama, Y. Hata, Y. Noda, M. Miura, I. Yamanaka, H. Shimokawa, and T. Ishibashi The Involvement of the Rho-Kinase Pathway and Its Regulation in Cytokine-Induced Collagen Gel Contraction by Hyalocytes Invest. Ophthalmol. Vis. Sci., November 1, 2004; 45(11): 3896 - 3903. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. H. Eibl, B. Banas, C.-L. Schoenfeld, C. A. May, A. S. Neubauer, S. Priglinger, A. Kampik, and U. Welge-Lussen Alkylphosphocholines Inhibit Proliferation of Human Retinal Pigment Epithelial Cells Invest. Ophthalmol. Vis. Sci., August 1, 2003; 44(8): 3556 - 3561. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |